Home > Financial Ratios > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -287.7079.82-108.19-80.9022.05

What is the latest Core EBITDA Growth ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?

The latest Core EBITDA Growth ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is -287.70 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar2023-287.70
Mar202279.82
Mar2021-108.19
Mar2020-80.90
Mar201922.05

How is Core EBITDA Growth of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?

Years Core EBITDA Growth % Change
Mar2023 -287.7
Negative
Mar2022 79.82
Positive
Mar2021 -108.19
Negative
Mar2020 -80.9
Negative
Mar2019 22.05 -

Other Financial Ratios of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


Compare Core EBITDA Growth ratio of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ₹107.7 Cr -1.7% -5.3% -37.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

-1.7%

-5.3%

-37.7%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses